logo
15:49 May 29

Balaxi Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
26.21
+1.24 (+4.97%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Balaxi Pharmaceuticals Ltd. Financials

Balaxi Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
26.21
+1.24 (+4.97%)
15:49 May 29
Quality
image/svg+xml

46/100
Medium Financial Strength

Valuation
image/svg+xml

39/100
Mid Valuation

Technical

43/100
Technically Neutral

Strength

5

Weakness

7

Opportunity

1

Threats

0

10.81 %

ROE %

8.07 %

ROA %

0.26

EPS

41.98

BVPS

8.56 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
231.33 279.39 336.43 241.29 292.56
Operating Expenses +
188.92 229.19 279.9 194.56 255.36
Raw Material
172.15 195.6 202.42 128.68 165.7
Increase Decrease in Cost
0 0 0 0 0
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
8.47 12.47 28.95 28.04 34.74
Miscellaneous Expenses
8.3 21.12 48.53 37.84 54.92
Operating Profit
42.41 50.2 56.53 46.73 37.2
Other Income
2.23 4.97 2.64 -2.65 -3.72
Depreciation
0.3 0.51 1.75 2.1 1.89
Interest
0.01 0.14 0.5 1.68 2.93
Profit before tax and exceptio..
44.33 54.52 56.92 40.31 28.67
Exceptional Items
0 0 0 -38.29 0
PBT
44.33 54.52 56.92 2.02 28.67
Provision for Taxation
6.19 6.86 10.96 4.4 3.6
Net Profit
38.14 47.66 45.96 -2.39 25.07
NET Profit after MI
38.14 47.66 45.96 -2.39 25.07
EPS
38.14 47.66 45.4 -2.32 4.54
Operating Profit Margin (%)
18.33 17.97 16.8 19.37 12.72
Net Profit Margin (%)
16.49 17.06 13.66 -0.99 8.57

Balaxi Pharmaceuticals Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 66.00 66.00 66.00 66.00 66.00 66.00
FII 0.00 1.70 3.50 8.90 16.00 16.50
Public 2.60 0.10 0.00 0.00 0.00 0.00
Others 31.40 32.20 30.50 25.10 18.00 17.50
Shareholder Shares Holding %
Research 360 logo
Download Our App On: